Table 3.
Results of cox regression (multivariate analysis) on late-stage cohort
| Parameter | HR | CI | p value |
|---|---|---|---|
| Differentiation moderate | 2.3 | 1.2–4.5 | 0.012 |
| Differentiation poor | 4.5 | 2–10.4 | 0.0001 |
| Carcinoma size (cm) | 1.14 | 1.01–1.3 | 0.031 |
| T stage 4 | 2 | 1.13–3.5 | 0.017 |
| Node stage 1 (0–2) | – | – | 0.32 |
| Node stage 2 (0–2) | – | – | 0.073 |
| Node stage 1b | – | – | 0.437 |
| Node stage 2a | – | – | 0.077 |
| Node stage 2b | – | – | 0.584 |
| HLA (normal epithelium) | – | – | 0.664 |
| HLA (normal stroma) | – | – | 0.277 |
| HLA (carcinoma epithelium) | – | – | 0.99 |
| HLA (carcinoma stroma) | – | – | 0.89 |
| No. of nodes | – | – | 0.584 |
Bolded p values < 0.05 were deemed statistically significant
–Indicates no HR or CI reported during statistical analysis when p > 0.05
HR hazard ratio, CI confidence interval